Aardvark Therapeutics, INC. (AARD) — S-1/A Filings
All S-1/A filings from Aardvark Therapeutics, INC.. Browse 1 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (1)
-
Aardvark Therapeutics Files IPO Amendment
— Feb 6, 2025 Risk: medium
Aardvark Therapeutics, Inc. filed an S-1/A amendment on February 6, 2025, for its initial public offering. The company, located at 4370 La Jolla Village Drive,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX